Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kageyama, Michiharu
25  Ergebnisse:
Personensuche X
?
1

Development of a novel in silico classification model to as..:

Umemori, Yuki ; Handa, Koichi ; Yoshimura, Saki..
Drug Metabolism and Pharmacokinetics.  55 (2024)  - p. 100902 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Development of Novel Methods for QSAR Modeling by Machine L..:

Handa, Koichi ; Yoshimura, Saki ; Kageyama, Michiharu.
Journal of Chemical Information and Modeling.  64 (2024)  9 - p. 3662-3669 , 2024
Link: https://doi.org/10.1021/..
 
?
3

Development of a Novel In Silico Classification Model to As..:

Umemori, Yuki ; Handa, Koichi ; Yoshimura, Saki..
Biomolecules.  14 (2024)  5 - p. 535 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Development of a 2D-QSAR Model for Tissue-to-Plasma Partiti..:

Handa, Koichi ; Sakamoto, Seishiro ; Kageyama, Michiharu.
European Journal of Drug Metabolism and Pharmacokinetics.  48 (2023)  4 - p. 341-352 , 2023
Link: https://doi.org/10.1007/..
 
?
5

On the difficulty of validating molecular generative models..:

Handa, Koichi ; Thomas, Morgan C. ; Kageyama, Michiharu..
Journal of Cheminformatics.  15 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
6

Prediction of Compound Plasma Concentration–Time Profiles i..:

Handa, Koichi ; Wright, Peter ; Yoshimura, Saki...
Molecular Pharmaceutics.  20 (2023)  6 - p. 3060-3072 , 2023
Link: https://doi.org/10.1021/..
 
?
7

Combined data-driven and mechanism-based approaches for hum..:

Handa, Koichi ; Sugiyama, Sakae ; Kageyama, Michiharu.
Digital Discovery.  2 (2023)  5 - p. 1577-1588 , 2023
Link: https://doi.org/10.1039/..
 
?
8

Stabilization and quantitative measurement of nicotinamide ..:

Matsuyama, Ryo ; Omata, Tomoyo ; Kageyama, Michiharu...
Analytical and Bioanalytical Chemistry.  415 (2022)  5 - p. 775-785 , 2022
Link: https://doi.org/10.1007/..
 
?
9

Cerebral and extracerebral distribution of radioactivity as..:

Ishii, Daisuke ; Kageyama, Michiharu ; Umeda, Shin.
PLOS ONE.  16 (2021)  12 - p. e0261451 , 2021
Link: https://doi.org/10.1371/..
 
?
10

Relationship between Excretion Clearance of Rhodamine 123 a..:

Kageyama, Michiharu ; Fukushima, Keizo ; Togawa, Tatsuya...
Biological and Pharmaceutical Bulletin.  29 (2006)  4 - p. 779-784 , 2006
Link: https://doi.org/10.1248/..
 
?
11

In Vivo Effects of Cyclosporin A and Ketoconazole on the Ph..:

Kageyama, Michiharu ; Namiki, Hitomi ; Fukushima, Hiroto...
Biological and Pharmaceutical Bulletin.  28 (2005)  2 - p. 316-322 , 2005
Link: https://doi.org/10.1248/..
 
?
12

Effect of Chronic Administration of Ritonavir on Function o..:

Kageyama, Michiharu ; Namiki, Hitomi ; Fukushima, Hiroto...
Biological and Pharmaceutical Bulletin.  28 (2005)  1 - p. 130-137 , 2005
Link: https://doi.org/10.1248/..
 
?
13

Evaluation of Factors to Decrease Plasma Concentration of a..:

Shibata, Nobuhito ; Kageyama, Michiharu ; Kimura, Keisuke...
Biological and Pharmaceutical Bulletin.  27 (2004)  2 - p. 203-209 , 2004
Link: https://doi.org/10.1248/..
 
?
14

Effect of Indinavir on the Intestinal Exsorption of Amprena..:

Gao, Weihua ; Kageyama, Michiharu ; Inoue, Yuji...
Biological and Pharmaceutical Bulletin.  26 (2003)  2 - p. 199-204 , 2003
Link: https://doi.org/10.1248/..
 
?
15

Pharmacokinetic characterization of a human immunodeficienc..:

Shibata, Nobuhito ; Kageyama, Michiharu ; Kishida, Tomoyuki...
Biopharmaceutics & Drug Disposition.  24 (2003)  8 - p. 335-344 , 2003
Link: https://doi.org/10.1002/..
 
1-15